Archives: Speakers

Matthew has over 20 yrs experience working for wealth managers, investment consultants and banks. His focus is now helping clients use technology to gain most efficiency from their operating model.

Originally from Rwanda and now based in Belgium, Révérien brings a unique blend of global experience and cultural insight to the clinical trial supply landscape.
With over 12 years of expertise in pharmaceutical supply chain management, he has successfully collaborated with leading companies such as Johnson & Johnson, Baxter, Thermo Fisher, and UCB.

Révérien’s academic background in IT and Supply Chain, combined with his deep understanding of clinical trial logistics, positions him as a forward-thinking expert in leveraging technology and innovation to optimize supply chains.
His focus includes improving trial diversity, enhancing efficiency, and ensuring patient safety through data-driven and patient-centered strategies.
As a passionate advocate for advancing clinical trials in underserved regions, Révérien is dedicated to addressing logistical challenges and fostering inclusivity in clinical research globally

Three University degrees at the University of Augsburg 5 years of Supply Chain Management responsibilities in automotive electronics industry 12 years of Management responsibilities in multiple roles (SCM, IT, Sales) in the pharma industry Since 2014 Head of Clinical Trial Supply (Sales) of Teva Europe. Offering Teva widest pipeline of pharmaceuticals, placebos and manufacturing for clinical trial purposes. Since 2017 Head of Global Health Tendering of Teva Global. Offering Teva widest pipeline to NGOs, GOs and UN related organizations. Married and father of three beautiful kids

Matthew Barnes is a clinical researcher specializing in project management, operational efficiency, and drug development. He has over 28 years of experience providing support for clinical trials in a variety of roles in both small to mid-sized pharmaceutical/biotech companies and Clinical Research Organizations (CROs). He is currently serving as the Director of Portfolio Management of Virpax Pharmaceuticals, where he is responsible for leading and coordinating cross-functional activities to advance non-clinical and clinical development programs, manufacturing activities, and the implementation and management of the Quality Management System and SOPs.

Rahul Malhotra has 16 years’ experience within the industry with academia and CROS, in the early stages of his career with Imperial College London. Rahul has worked in multiple Therapeutic areas, with many of those years in Oncology, predominantly global operations and building strategic full service partnerships with Large Pharma and Bio Techs. Rahul has managed and taken an oversight role for multiple and simultaneous global projects in over 26 countries; managing large full service teams and actively presenting in a range of meetings and conferences across the globe. He has a passion for Oncology, working collaboratively and transparently with his colleagues and clients by delivering the highest level of competency, by ensuring every objective is met with extreme care and competence.